Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion

被引:33
|
作者
Moreiro, J. [1 ]
Ruiz, O. [1 ]
Perez, G. [1 ]
Salinas, R. [1 ]
Urgeles, J. R. [1 ]
Riesco, M. [1 ]
Garcia-Sanz, M. [1 ]
机构
[1] Univ Hosp Son Duerta, Palma de Mallorca 07003, Spain
关键词
morbid obesity; bariatric surgery; biliopancreatic diversion; secondary hyperparathyroidism; parathyroid hormone; vitamin D; bone markers; intestinal malabsorption; short intestine syndrome;
D O I
10.1007/s11695-007-9063-9
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Scopinaro biliopancreatic diversion (BPD) is associated with malabsorption of calcium and vitamin D, which manifests as a secondary hyperparathyroidism (SHP) and may lead to osteopenia. Methods: 96 morbidly obese patients were studied (age 19-60 years, 23 men and 73 women, with mean initial BMI 53) following intervention by Scopinaro BPD. The change in iPTH levels, urine DPD, Pyrilinks-D of DPC and serum CTx were studied at 0, 3,6,12,18 and 24 months after surgery. Postoperatively, they were given supplements of calcium and vitamin D3. The control group consisted of 67 non-obese women and 10 men. Results: The iPTH levels gradually increased after BPD, with a substantial difference compared to pre-surgery levels at month 6. In spite of the calcium and vitamin D supplements, 77% of the patients with pre-surgery SHP did maintain high levels of WTH after 2 years. The percentage of SHP among the patients with normal pre-surgery iPTH was 58%. The basal figures of DPD/cre were significantly higher than in the control group, 9.06 (4.6-13.5) nM/mMcre vs 3.9 (2.8-5.6) in men and 6.75 (5.4-7.9) vs 7.67 (3.3-11.6) in women, but not CTx, 0.24 (0.02-0.89) vs 0.22 (0.07-0.55). After the operation, there was a noticeable increase which persisted at 2 years. There was a lack of correlation between the levels of WTH and the bone resorption markers, i.e. the first ones decreased from month 6 in men and from month 12 in women, while the levels of WTH continued to increase. Conclusion: In obese patients, we found no correlation between WTH levels and BMI. Supplements of calcium and vitamin D did not prevent the appearance of SHP following BPD. The patients with high pre-surgery WTH levels have a higher risk of malabsorption of calcium and vitamin D. Following malabsorptive bariatric surgery, there is an increase in bone resorption, which results in DPD and CTx increase. Those markers do not correlate with iPTH, and this may suggest that there is a phenomenon of bone reshaping parallel to the loss of. weight.
引用
收藏
页码:348 / 354
页数:7
相关论文
共 50 条
  • [31] Evaluation of antioxidant systems (coenzyme Q10 and total antioxidant capacity) in morbid obesity before and after biliopancreatic diversion
    Mancini, Antonio
    Leone, Erika
    Festa, Roberto
    Grande, Giuseppe
    Di Donna, Vincenzo
    De Marinis, Laura
    Pontecorvi, Alfredo
    Tacchino, Roberto Maria
    Littarru, Gian Paolo
    Silvestrini, Andrea
    Meucci, Elisabetta
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (10): : 1384 - 1389
  • [32] Liver Transplantation in a Case of Steatohepatitis and Subacute Hepatic Failure after Biliopancreatic Diversion for Morbid Obesity
    Julio Castillo
    Emilio Fábrega
    Carlos F Escalante
    Juan Carlos R Sanjuan
    Luis Herrera
    Fernando Hernánz
    Esteban Martino
    Fernando Casafont
    Manuel Gómez Fleitas
    [J]. Obesity Surgery, 2001, 11 : 640 - 642
  • [33] Incidence of secondary hyperparathyroidism after biliopancreatic diversion with duodenal switch for morbid obesity: an underestimated phenomenon
    Nett, Philipp C.
    Borbely, Yvesm.
    Plitzko, Gabriel
    Kroll, Dino
    [J]. OBESITY SURGERY, 2018, 28 : S19 - S19
  • [34] Liver transplantation in a case of steatohepatitis and subacute hepatic failure after biliopancreatic diversion for morbid obesity
    Castillo, J
    Fábrega, E
    Escalante, CF
    Sanjuan, JCR
    Herrera, L
    Hernánz, F
    Martino, E
    Casafont, F
    Fleitas, MG
    [J]. OBESITY SURGERY, 2001, 11 (05) : 640 - 642
  • [35] β-Cell Function Improvement After Biliopancreatic Diversion in Subjects With Type 2 Diabetes and Morbid Obesity
    Briatore, Lucia
    Salani, Barbara
    Andraghetti, Gabriella
    Maggi, Davide
    Adami, Gian Franco
    Scopinaro, Nicola
    Cordera, Renzo
    [J]. OBESITY, 2010, 18 (05) : 932 - 936
  • [36] Biliopancreatic Diversion for Treatment of Morbid Obesity: Experience in 180 Consecutive Cases
    Erik Totté
    Leo Hendrickx
    Robrecht van Hee
    [J]. Obesity Surgery, 1999, 9 : 161 - 165
  • [37] Biliopancreatic diversion for treatment of morbid obesity:: Experience in 180 consecutive cases
    Totté, E
    Hendrickx, L
    van Hee, R
    [J]. OBESITY SURGERY, 1999, 9 (02) : 161 - 165
  • [38] Complications of biliopancreatic diversion surgery as proposed by Scopinaro in the treatment of morbid obesity
    Michielsen, D
    VanHee, R
    Hendrickx, L
    [J]. OBESITY SURGERY, 1996, 6 (05) : 416 - 419
  • [39] Colorectal cancer after biliopancreatic diversion for obesity
    G F Adami
    F S Papadia
    N Scopinaro
    [J]. International Journal of Obesity, 2007, 31 : 1864 - 1864
  • [40] A lytic bone lesion after biliopancreatic bypass surgery for morbid obesity.
    Laga, K
    Van den Bruel, A
    Vanderschueren, D
    Bex, M
    Mathieu, C
    Samson, I
    Dedeurwaerdere, F
    Bouillon, R
    Muls, E
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S414 - S414